. Author manuscript; available in PMC: 2015 Mar 1.

Published in final edited form as: Am J Transplant. 2014 Mar;14(3):621–628. doi: 10.1111/ajt.12564

Table 6.

One-year survival and hazard ratio for survival in organ recipients randomized to placebo versus albuterol

	Placebo		Albuterol		Comparison
	N	1-year Survival¹ (%) [95% CI]	N	1-year Survival¹ (%) [95% CI]	Hazard Ratio¹,² 95% CI]	P-value¹
Lung recipients	80	0.89 [0.84 – 0.95]	79	0.83 [0.76 – 0.90]	1.46 [0.86 – 2.48]	0.16
Liver recipients	203	0.88 [0.85 – 0.93]	221	0.90 [0.86 – 0.93]	0.89 [0.56 – 1.42]	0.63
Kidney recipients	416	0.97 [0.95 – 0.98]	371	0.97 [0.96 – 0.99]	0.74 [0.42 – 1.3]	0.29
Heart recipients	97	0.85 [0.79 – 0.92]	92	0.92 [0.87 – 0.97]	0.53 [0.26 – 1.07]	0.08

: Survival probabilities, hazard ratios, and confidence intervals were estimated with univariate Cox proportional-hazards models. To account for repeated measures due to shared donors (except for heart recipients), a GEE approach was used in the Cox proportional hazard model. The lung transplantation model was further adjusted for transplantation type (single, double, heart/lung).

: Albuterol vs. Placebo